Spectra Systems: Pioneer in Machine-Readable Covert Polymer Substrate

0

Spectra Systems received positive responses on the introduction of their machine-readable covert polymer substrate at the Banknote Conference.

Spectra Systems focuses on security technology inclusive of both software and materials to be used in gaming, product authentication and banknotes.

TruNote and Trutrack are two proprietary products of Spectra Systems. TruNote enables smart phones to detect materials that prove the authenticity of banknotes. Trutrack tracks the authenticity and geographic location of banknotes.

During the conference in Washington, Spectra Systems introduced for the first time, Fushion machine-readable, covert polymer substrate. This substrate is a breakthrough in banknote protection. The presentation organised by Dr. Nabil Lawandy, Chief Executive Officer, received great reactions by the attendees.

With the help of biaxially oriented polypropylene (BOPP), Spectra created the new covert polymer substrate. The substrate allows for high speed authentication and very good reliability in banknote security. The product allows central banks to create their own unique codes which would detect and be verified by the paired sensor system.

The current capacity for these substrates is 2 billion notes per year, with that capacity expected to expand to 10 billion by the end of 2020.

Dr. Nabil Lawandy, Chief Executive Officer of Spectra, stated, “We are extremely pleased with the response to our breakthrough product and the opportunity to have in person discussions with potential customers and strategic partners.”

BAE Systems reports strong profits of £19.5bn

0

BAE Systems have reported strong profits of £19.5 billion in its financial results for 2021 and have defied the current market trend with a share price increase of 1.93% to 612.4p.

The profit marks a £0.3 billion bump up in profit from the company’s financial results in 2020.

The UK’s biggest defence contractor further reported basic earnings per share of 55.2p against results of 40.7p in 2020.

BAE Systems also reported a sales increase of £21.3 billion against 2020 sales of £20.8 billion.

The company mentioned that its growth for 2022 was projected to stem from electronic systems, air, maritime and cyber and intelligence segments, with BAE System’s Platforms & Services (US) estimated to remain stable.

“Our strong results reflect the outstanding efforts of our employees who have continued to adapt and work closely with our customers, suppliers and trades unions to deliver capabilities which keep nations and citizens safe,” said BAE Systems CEO Charles Woodburn.

“We are continuing to evolve our business, increasing our investments in advanced technologies to deliver differentiated solutions to meet our customers’ priorities.”

“Our diverse portfolio, together with our focus on programme execution, cash generation and efficiencies, is helping us to navigate the challenging operating environment, meaning we are well positioned for sustained top line and margin growth in the coming years.”

Evraz shares: is now a good time to buy?

Evraz shares are trading down 30% at the time of writing as Russia launches a full scale invasion of Ukraine, sending troops into the country and launching rocket attacks on cities.

The flagrant disregard for Ukraine’s sovereignty by Putin has rocked European markets, in particular those with operations or links to Russia, including FTSE 100 Evraz.

The Evraz share price was down 30% on Thursday and has collapsed by 71% so far in 2022. Indeed, the company is trading more like a penny share than a FTSE 100 constituent. Such a sharp decline in Evraz shares will likely grab the attention of bargain hunters, but is now a good time to buy Evraz shares?

With such a high degree of uncertainty around the situation on the ground, and what impact sanctions will have on Russian businesses, considering taking a position in Russia-Exposed companies will be pursuit only for the brave.

“Investors hate uncertainty and whilst it’s inevitable that the west will respond to Russia’s aggression, what’s unclear right now is by what severity and how the situation could escalate further. As a result, investors are seeking asset protection and don’t want to take on any risk to their portfolios,” said Walid Koudmani, chief market analyst at financial brokerage XTB.

Evraz shares have suffered due their substantial steel-making operations across Russia. Of Evraz’s total Q4 crude steel production of 3,384,000 tonnes, 2,904,000 tonnes were produced in Russia.

The West is promising serve sanctions on Russia which will likely target their commodity exports which would ravage the ability of Evraz to export steel and destroy their revenue and prices achieved for their output. Steel could well be high on the West’s list of exports to targets as curbing their oil exports would harm their own economies as much as Russia’s.

One only has to look at what the West has done to the Iranian oil industry and economy with the implementation of sanctions.

Adventurous short-term traders may look to the Evraz share price for a ‘dead cat bounce’, but the longer term outlook for Evraz shares is highly uncertain and buying Evraz should be considered extremely high risk.

European markets rocked as Russia launches full scale invasion

European markets were rocked on Thursday by the news Russia had launched a full scale invasion of Ukraine which was met by the promise of server sanctions by the West.

European equities opened sharply lower on Thursday in a broad risk off move in equities and commodities soared of supply disruption fears.

The FTSE 100 was trading down by 2.2% at 7,328 in early trade on Thursday. The German Dax plunged more than 3%.

While equities sank, energy prices jumped on concerns supply would face severe disruptions, and oil broke the $100 mark.

European TTF Natural Gas Futures jumped around 30% piling on pressure for households across the region who have already seen bills increase.

“Markets woke up in panic mode as investors reacted to the news overnight of Russia’s invasion of Ukraine. We have seen clients sell out of risky asset classes such as stocks and buy gold and the US dollar which are seen as safer investments at times of uncertainty. We have seen oil prices charge higher with Brent Oil trading above $100 for the first time since 2014. This will have further consequences to the cost of living and inflation in Europe,” said Walid Koudmani, chief market analyst at financial brokerage XTB.

European shares sink

European shares experienced sharp selling on Thursday with sectors linked to Russia the most heavily hit. The West has promised a server package of sanctions that will likely cause economic hardships for Russia businesses and individuals.

Shares in FTSE 100 Polymetal and Evraz crashed 31% and 29% respectively as investor fled companies that relied on Russia for their business operations. Polymetal and Evraz have substantial mining operations across Russia.

Travel shares were heavily hit over fears the conflict could put people off from booking or taking holidays. IAG shares gave up 4.6% and FTSE 250 easyJet sank 4.9%.

Although oil prices jumped to the highest levels in six years, oil companies also slipped with Shell giving up 1.5% and BP sinking by 3.8%.

BP is particularly exposed to any additional sanctions that would impact energy supply between Russia and Europe.

The FTSE 100 was trading off its worst levels of the session at the time of writing.

Lloyds £6.9bn profits disappoint shareholders

1

Lloyds Banks announced strong profits of £6.9 billion in its end of year results for 2021, however its results fell below analyst-predicted profits of £7.2 billion.

Lloyds’ share price has taken a major hit with the stock dropping 7.3% to 48.37 in the early morning, although the crisis in Ukraine would account for much of the drop.

Dividends have been reported at 2p per ordinary share and earnings per share at 7.5p, with a share buyback scheme of £2 billion reported by the bank.

Lloyds enjoyed a boost to underlying profit as a result of £1.2 billion in emergency reserves the bank allocated to help with pandemic-linked defaults on loans which were subsequently unneeded.

“In the context of continued business momentum and balance sheet growth, the Group has delivered a solid financial performance with statutory profit after tax of £5.9 billion, significantly higher than 2020,” said Lloyds Bank CEO Charlie Nunn.

“Increased profits benefitted from higher income and the net underlying impairment credit of £1.2 billion in 2021, driven by improvements to the macroeconomic outlook for the UK, combined with robust observed credit performance.”

“Underlying profit before impairment of £6.8 billion was up 6 per cent on 2020, with increased average interest-earning assets, a strengthened banking net interest margin and early signs of recovery in other income, alongside a reduction in operating lease depreciation.”

It was not entirely good news for the FTSE 100 company, however, as its financial results were significantly dented by fraud costs from the HBOS Reading sector.

The bank was forced to pay £1.3 billion pounds, alongside a charge of £600m for costs linked to fraud at its HBOS Reading branch.

“Remediation charges increased in the year to £1,300 million, with £775 million in the fourth quarter,” said Nunn.

“The full year remediation charges relate to a number of pre-existing legacy issues and include a £790 million charge relating to HBOS Reading which reflects the Group’s estimate of its full liability, albeit significant uncertainties remain.”

“We continue to support the independent Foskett Panel re-review and Dame Linda Dobbs’ independent review process as we work to bring this matter to a conclusion.”

Hikma Pharmaceutical enjoys 9% revenue growth and strong momentum across the business

2

Hikma revenues grew 9% from $2.3bn to $2.5bn as core operating profit increased by 12% from $566m to $632m.

The EPS remained unchanged and the reported profit which is distributed amongst the shareholders reduced by 2%. Dividend payout for the full year increased by 4 cents.

Hikma Pharma also announced a change in their board of directors on Thursday morning.

Hikma Pharmaceuticals has business divisions: injectables, generic and branded.

Plans for Growth

Hikma launched Advair Diskus last April and is preparing for steady growth and market share through 2022.

The Pharma group plans to expand distribution of specialty products in the US, which includes the launch of a nasal spray, Kloxxado 8mg naloxone.

Injectables are in the process of gaining potential growth by the signing of 2 US biosimilar agreements.

Eight oral oncology products in Algeria have been added to the Branded portfolio.

The Group plans to reduce their greenhouse gas emissions by 25% till 2030.

“Hikma delivered strong financial results in 2021, marking another successful year of solid growth and continued strategic momentum. Our operational strength and high quality standards ensured our ability to provide customers with a consistent supply of essential medicines in a challenging environment. I am grateful to Hikma colleagues around the world for their steadfast commitment to helping the millions of patients who rely on our medicines every day,” said Siggi Olafsson, Chief Executive Officer of Hikma. 

“As we look to 2022 and beyond, I am most excited about how we are continuing to build and evolve our portfolio with important investments and new partnerships. Our Injectables business is now supplying US hospitals with sterile compounded pharmaceutical products, has expanded into Canada, and is set to grow further with the acquisition of Custopharm and our expansion into US biosimilars. Our Generics business is bringing more complex and specialty products to market, launching Kloxxado and generic Advair Diskus in 2021, and with additional product launches planned for this year. Our Branded business is delivering consistent growth, with an increased focus on medications to treat chronic illnesses. We have an exciting platform that will drive continued growth and progress in the year ahead.”

Seeing Machines accelerates

Seeing Machines (LON: SEE) is making good progress and car manufacturers are installing its driver monitoring systems in more models. Interim revenues are 19% ahead at A$21.7m.
Seeing Machines develops artificial intelligence-based computer vision technologies. There are many potential uses, but the focus is the automotive market. Driver monitoring systems (DMS) are becoming a mass market due to regulatory changes.
Up until now, the main revenues were coming from Guardian fleet system monitors – annualised recurring revenues are running at A$18.8m. This is changing as the car manufacturers fit...

Seraphim Space IT taking off

Seraphim Space Investment Trust (LON:SSIT) has performed strongly since it floated and there is more to come.
The portfolio has 21 companies, most of which were acquired at the time of the flotation. There are plenty of potential investments in the space sector, some of which come out of the Seraphim accelerator programme. There are also other investors interested in the sector so plenty of money is available for funding rounds.
Three of the investments are quoted in the US. This includes the company’s largest investment Arqit Quantum, which is valued at £47.9m. Arqit Quantum is developing a c...

Trident Royalties Investor Presentation February 2022

Trident Royalties presents at the UK Investor Magazine Metals & Mining Investor Conference.

Trident believes that the acquisition and aggregation of individual royalties and streams has the potential to deliver strong returns for shareholders as assets are acquired on terms reflective of single asset risk compared with the lower risk profile of a diversified, larger scale portfolio, including diversity as to geography (lowering geopolitical risks) and commodity exposure.

Download Investor Presentation Slides Here

Cadence Minerals Investor Presentation February 2022

Cadence Minerals is an early stage investment and development company within the mineral resource sector and is listed as an investment company on the London Stock Exchange AIM market and the Aquis Stock Exchange, also based in London.

Download Presentation Slides Here.